| 000 | 01335 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513090700.0 | ||
| 264 | 0 | _c19960624 | |
| 008 | 199606s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaul, D M | |
| 245 | 0 | 0 |
_aPaclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cFeb 1996 |
||
| 300 |
_a48-52 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 700 | 1 | _aGarrett, A M | |
| 700 | 1 | _aMeshad, M | |
| 700 | 1 | _aDeVore, R D | |
| 700 | 1 | _aPorter, L L | |
| 700 | 1 | _aJohnson, D H | |
| 773 | 0 |
_tSeminars in oncology _gvol. 23 _gno. 1 Suppl 1 _gp. 48-52 |
|
| 999 |
_c8628077 _d8628077 |
||